TG Therapeutics Profit Margin 2006-2018 | TGTX
Current and historical gross margin, operating margin and net profit margin for TG Therapeutics (TGTX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. TG Therapeutics net profit margin as of December 31, 2018 is -98576.14%.
|TG Therapeutics Annual Profit Margins
|TG Therapeutics Quarterly Profit Margins
||Medical Products Manufacturing
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.